|
MTMR6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.42179609699633E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.32489996751417E-09 |
| Normal-vs-Stage2 |
3.804900000004E-05 |
| Normal-vs-Stage3 |
2.17650009126658E-10 |
| Normal-vs-Stage4 |
2.89030022138093E-10 |
| Stage1-vs-Stage2 |
9.711200E-01 |
| Stage1-vs-Stage3 |
1.303600E-01 |
| Stage1-vs-Stage4 |
4.710100E-02 |
| Stage2-vs-Stage3 |
3.194000E-01 |
| Stage2-vs-Stage4 |
1.403590E-01 |
| Stage3-vs-Stage4 |
4.427400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.92970117452296E-13 |
| Normal-vs-AfricanAmerican |
1.195770E-02 |
| Normal-vs-Asian |
9.76519999973391E-07 |
| Caucasian-vs-AfricanAmerican |
3.381900E-02 |
| Caucasian-vs-Asian |
6.117400E-01 |
| AfricanAmerican-vs-Asian |
1.535170E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.60700383292578E-11 |
| Normal-vs-Female |
4.00170008241219E-10 |
| Male-vs-Female |
1.116980E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.13190000039509E-07 |
| Normal-vs-Age(41-60Yrs) |
3.51899620554263E-11 |
| Normal-vs-Age(61-80Yrs) |
1.87790005767852E-10 |
| Normal-vs-Age(81-100Yrs) |
1.140310E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.281240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.843700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.268400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.435000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.945600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.388200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.357400E-01 |
| Classical-VS-Follicular |
6.808000E-01 |
| Classical-VS-Other |
5.521900E-02 |
| Classical-VS-Normal |
6.76700029345056E-10 |
| Tall-VS-Follicular |
4.354400E-01 |
| Tall-VS-Other |
1.938590E-01 |
| Tall-VS-Normal |
8.64220000007521E-07 |
| Follicular-VS-Other |
1.596630E-01 |
| Follicular-VS-Normal |
1.25959999996983E-06 |
| Other-VS-Normal |
1.193600E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.26579977002928E-10 |
| Normal-vs-N1 |
3.60290020040566E-10 |
| N0-vs-N1 |
1.611160E-01 |
|
|
